Moderna Clinical Trials

Moderna Gets $590 Million in Federal Funding

Hosted on MSN · 15h

Moderna Is Getting $590 Million From the U.S. to Accelerate a Bird Flu Vaccine

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Reuters · 15h

US awards Moderna $590 million for bird flu vaccine development

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

Forbes · 3d

Moderna May Have The Best Shot At A Vaccine For Stomach Flu

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

Business Insider · 15h

Moderna confirms $590M award by U.S. for bird flu vaccine development

Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of

The Wall Street Journal on MSN · 15h

Moderna Gets $590 Million of Federal Funding For Influenza Vaccines

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the company said

AFP on MSN · 11h

US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

justthenews11d

Moderna buried child's death in COVID booster trial in EU report, FDA response called 'misleading'

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares tumble

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

조선일보8d

Moderna starts clinical trials in South Korea for combo flu and COVID-19 vaccine

Moderna advances combo vaccine for flu and COVID-19 with trials starting in March Pharmaceutical companies gear up to tackle ...

The Economist1d

How to improve clinical trials

Even so, broadening the range of trials’ participants can be practically useful, because they may lead to new medical ...

AOL7d

Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.

Moderna is betting on mRNA technology to do just that. To Fink’s knowledge, none of its competitors has made it to Phase 3 of a clinical trial involving an mRNA norovirus vaccine. The goal of ...

15h

Moderna Announces Updates on Pandemic Influenza Program

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...

Moderna Faces Financial Uncertainty Amid Market Competition and Revenue Challenges

Analyst Mani Foroohar of Leerink Partners maintained a Sell rating on Moderna (MRNA – Research Report), reducing the price target to ...

FiercePharma4d

JPM25: Moderna slashes guidance, plots $1B in cost cuts this year amid lackluster vaccine sales

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results